Log in

NYSE:ANIXITUS Stock Price, Forecast & News

$3.06
+0.14 (+4.79 %)
(As of 07/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.82
Now: $3.06
$3.84
50-Day Range
$1.85
MA: $2.24
$2.92
52-Week Range
$1.33
Now: $3.06
$5.45
Volume818,300 shs
Average Volume210,385 shs
Market Capitalization$70.31 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Anixa Biosciences, Inc. engages in the development, acquisition and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body's immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.76 out of 5 stars


Industry, Sector and Symbol

Industry Computer Peripherals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
WebN/A
Phone(408) 708-9808

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$70.31 million
Next Earnings Date9/4/2020 (Estimated)
OptionableNot Optionable

Receive ANIX News and Ratings via Email

Sign-up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter.

ITUS (NYSE:ANIX) Frequently Asked Questions

How has ITUS's stock been impacted by COVID-19 (Coronavirus)?

ITUS's stock was trading at $2.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ANIX shares have increased by 47.8% and is now trading at $3.06. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of ITUS?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ITUS in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ITUS.

When is ITUS's next earnings date?

ITUS is scheduled to release its next quarterly earnings announcement on Friday, September 4th 2020. View our earnings forecast for ITUS.

How were ITUS's earnings last quarter?

ITUS Corporation (NYSE:ANIX) issued its quarterly earnings data on Tuesday, June, 9th. The company reported ($0.12) EPS for the quarter. View ITUS's earnings history.

What price target have analysts set for ANIX?

2 analysts have issued 1-year target prices for ITUS's shares. Their forecasts range from $8.00 to $8.50. On average, they expect ITUS's share price to reach $8.25 in the next twelve months. This suggests a possible upside of 169.6% from the stock's current price. View analysts' price targets for ITUS.

Has ITUS been receiving favorable news coverage?

Headlines about ANIX stock have trended very negative this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. ITUS earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about ITUS.

Who are some of ITUS's key competitors?

What other stocks do shareholders of ITUS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ITUS investors own include Bank of America (BAC), Gilead Sciences (GILD), Applied DNA Sciences (APDN), Digital Turbine (APPS), Alibaba Group (BABA), AbbVie (ABBV), Blink Charging (BLNK), Commercial Metals (CMC), IBM (IBM) and Advanced Micro Devices (AMD).

Who are ITUS's key executives?

ITUS's management team includes the following people:
  • Amit Kumar, Executive Chairman, President & CEO
  • Michael J. Catelani, Chief Operating & Financial Officer
  • John A. Roop, Senior Vice President-Engineering
  • Anthony Campisi, Vice President-Engineering

What is ITUS's stock symbol?

ITUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANIX."

How do I buy shares of ITUS?

Shares of ANIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ITUS's stock price today?

One share of ANIX stock can currently be purchased for approximately $3.06.

How big of a company is ITUS?

ITUS has a market capitalization of $70.31 million.

How can I contact ITUS?

The company can be reached via phone at (408) 708-9808.

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.